telomerase

The reason telomerase has this effect in human cells is clear.

But its main focus has been on turning off telomerase to fight cancer.

In most human cells there is no sign of telomerase activity.

Not all types of human cancer have increased telomerase activity.

And it owns the rights to a human protein called telomerase.

But it has taken longer than expected to find a drug that shuts off telomerase.

Next you were given a drug that stimulated the production of telomerase.

"You were due to be given a shot of telomerase stimulator in less than two months."

They also added telomerase, which allows cells to double without limits.

Cancer cells produce telomerase, which lets them reproduce out of control.

So a drug that turns off telomerase has potential use in treating all kinds of cancers.

This is largely due to the activity of the enzyme known as telomerase.

This process does not take place in cancer cells due to an enzyme called telomerase.

If a patient were simply treated with telomerase inhibitor, death would soon follow.

The telomerase gene is switched off almost entirely in normal cells.

But the company does not plan to give patients cells with permanently activated telomerase, if it can avoid doing so.

For their achievements in the discovery of telomeres and telomerase.

The potential remains for telomerase activators to contribute to the development of cancer.

Enhanced telomerase activity can be an indicator of abnormal cells.

The gene is one that makes the critical component of an enzyme called telomerase.

This could be why heart attacks can come on so suddenly: Telomerase is driving the growth of the blockage.

In 2009, it was shown that the amount of telomerase activity significantly increased due to psychological stress.

In a disease where telomerase is affected, it does not seem to follow that cancer would be a complication to result.

This is because they contain raised amounts of telomerase.